Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Centogene N.V.
(NQ:
CNTG
)
0.4503
-0.0296 (-6.17%)
Streaming Delayed Price
Updated: 2:43 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Centogene N.V.
< Previous
1
2
3
4
5
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 19, 2024
Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning!
Via
InvestorPlace
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
April 19, 2024
Via
Benzinga
CENTOGENE Receives Nasdaq Non-Compliance Notice
April 02, 2024
From
Centogene NV
Via
GlobeNewswire
Analyst Expectations for Centogene's Future
June 28, 2023
Via
Benzinga
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
March 19, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
February 29, 2024
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
February 28, 2024
Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Explores Strategic Alternatives
February 28, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
January 25, 2024
Aims to Leverage Diversified Data to Accelerate and De-Risk Drug Discovery and Clinical Development
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Receives French Research Tax Credit Accreditation
January 24, 2024
Partners able to claim up to 30% tax relief
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
January 23, 2024
Collaboration to accelerate research to determine role of GBA gene
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Preliminary Full Year 2023 Revenue
January 18, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Voting Results of Extraordinary General Meeting
December 19, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
December 13, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
November 28, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
November 14, 2023
Results From Landmark Study Published in Brain Journal
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
October 10, 2023
Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Reports First Half 2023 Financial Results
September 07, 2023
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
September 01, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
August 31, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in August
August 07, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
July 14, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
July 12, 2023
Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment Options
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
June 30, 2023
From
Centogene NV
Via
GlobeNewswire
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
June 29, 2023
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 29, 2023
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
Via
InvestorPlace
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
June 28, 2023
Gainers Theriva Biologics, Inc. (NYSE: TOVX) shares surged 76.4% to $1.46 in pre-market trading after the company said Orphan Drug Designation was granted by the U.S. Food and Drug Administration for...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 28, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.